In 2023, the hospital discharge rate for leiomyoma of the uterus in France was recorded at 86.0 per hundred thousand persons. Forecasted values from 2024 to 2028 indicate a slight decline with the rate stabilizing at 85.9 by 2027. The five-year CAGR shows minimal change, reflecting stability in hospital discharges for this condition.

Future trends to watch for include the impact of advancements in medical treatments and preventive care, which could further reduce hospitalization rates. Also, demographic changes and healthcare policies in France may influence these trends, necessitating ongoing analysis of hospital discharge data.

2023: 86.0
2024: 86.0
2025: 86.0
2026: 86.0
2027: 85.9
2028: 85.9